Clinical trials
Phase 2 Liver Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 12 |
| Completed | 5 |
| Not yet recruiting | 4 |
| Recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 2 |
| Second Affiliated Hospital of Guangzhou Medical University | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Affiliated Hospital of Guangdong Medical University | 1 |
| Beijing 302 Hospital | 1 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. | 1 |
| Bristol-Myers Squibb | 1 |
| Fuda Cancer Hospital, Guangzhou | 1 |
| Guangxi Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 25 |
| Carcinoma, Hepatocellular | 8 |
| Digestive System Neoplasms | 3 |
| Carcinoma | 2 |
| Colorectal Neoplasms | 2 |
| Liver Diseases | 2 |
| Lung Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Biliary Tract Neoplasms | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.